<DOC>
	<DOCNO>NCT00916383</DOCNO>
	<brief_summary>This study design assess skin tolerability , skin irritation , adhesion 350 mg Donepezil Transdermal Patch ( DTP-system ) , follow 3 , 7-day application 3 specific area body ( upper back , upper middle arm , side torso ) elderly Alzheimer 's patient . The total application time DTP-system 21 day .</brief_summary>
	<brief_title>Study Elderly Alzheimer 's Patients Assess Skin Tolerability , Irritation With 3 , 7-Day Applications DTP-System</brief_title>
	<detailed_description>This randomize , placebo-controlled study design evaluate skin irritation , skin tolerability , adhesion 350 mg DTP-system follow 3 consecutive 7-day application 3 specific area body ( upper back , upper arm , side torso ) elderly Alzheimer 's patient . The total exposure time DTP-system 21 day . All patient receive 1 Donepezil Transdermal Patch ( DTP-system ) 1 placebo patch , apply opposite side body ( e.g. , placebo patch leave side upper back , DTP-system right side upper back ) . Patients randomize receive active patch either leave right side body accord 1 6 treatment sequence list . The treatment sequence repeat opposite side body total 12 treatment sequence ( 4 patient treatment sequence ) . The patch apply one 3 body location 7 day , total exposure period 21 day , accord one follow sequence : 1 . Upper Back , Upper Arm , Side Torso ( Right ) 2 . Upper Arm , Side Torso , Upper Back ( Right ) 3 . Side Torso , Upper Back , Upper Arm ( Right ) 4 . Upper Back , Side Torso , Upper Arm ( Right ) 5 . Upper Arm , Upper Back , Side Torso ( Right ) 6 . Side Torso , Upper Arm , Upper Back ( Right ) 7 . Upper Back , Upper Arm , Side Torso ( Left ) 8 . Upper Arm , Side Torso , Upper Back ( Left ) 9 . Side Torso , Upper Back , Upper Arm ( Left ) 10 . Upper Back , Side Torso , Upper Arm ( Left ) 11 . Upper Arm , Upper Back , Side Torso ( Left ) 12 . Side Torso , Upper Arm , Upper Back ( Left ) Patches apply Days 1 , 8 , 15 accord randomization schedule . Oral Aricept take daily Day -1 , re-started Day 22 time early termination Day 22 . Patients see clinic Screening Days 1 , 8 , 15 , 22 , End Study Visit ; daily visit , patient may see either clinic residence , provide assessment complete described protocol . Skin irritation assess immediately upon patch removal 1 , 24 , 48 hour removal .</detailed_description>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Male female least 65 year age . Established dose Aricept 10 mg least 2 month prior enrollment . Established diagnosis stable Alzheimer 's disease treat oral Aricept Must willing change oral Aricept DTP ( placebo patch ) . Body mass index least 18 minimum weight least 45 kg . Blood pressure ( sit ) must diastolic &lt; 95mmHg , systolic &lt; 145 , stable least 3 month . Patients wellcontrolled hypertension ( medication ) may enroll long 3month stability criterion meet . Those stable cardiac disease may enrol provide patient appropriate medication 3 month prior screen . Those pacemaker may enrol . Pulse rate 45 100 bpm ; respiration 8 20 per minute . Those thyroid disease may enroll stable treatment least 3 month prior screen , maintain dose thyroid medication throughout study . Must caregiver either living patient daily contact patient , agree present visit , provide information require , ensure compliance medication schedule . Free abnormality Screening may compromise patient 's ability participate . Free dermatologic condition , excessive hair skin allergy sensitivity . Male patient female partner childbearing potential must use condom . Must understand provide write informed consent ( Legally Authorized Representative able ) , prior initiation protocolspecific procedure . Must willing able abide study requirement restriction . Must stable medication least 30 day prior enrollment study . Use systemic topical antihistamine within 72 hour prior enrollment , systemic topical corticosteroid within 3 week study enrollment foreseen use study . History allergy Donepezil hydrochloride piperidine derivative , relate drug , drug excipients drug product component . Those recent ( &lt; 2 year ) cancer ( except nonmelanoma skin cancer , female insitu cancer cervix male localize prostate cancer require treatment ) . Presence history psychiatric disorder , seizure disorder deem clinically significant . Those known plan elective surgery study period . Those take antidepressant medication . Abnormality ( e.g. , scar , tattoo ) unhealthy skin ( e.g. , burn , wound ) application site ; exist chronic skin disease history skin disease application site ( ) within 30 day prior enrollment . Treatment investigational drug within 30 day prior enrollment study . Any condition would make patient caregiver , opinion investigator designee , suitable study reason . Current pending legal charge may affect patient caregiver compliance . Treatment medication contraindicate use Aricept</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Skin Irritation</keyword>
	<keyword>Donepezil Transdermal Patch System</keyword>
	<keyword>Elderly</keyword>
	<keyword>Alzheimer 's subject</keyword>
	<keyword>Skin Irritation elderly Alzheimer 's subject</keyword>
</DOC>